Singulair, originally sold by Merck & Co., is a prescription drug that was launched in 1998 and is used to prevent and treat symptoms of asthma and allergies, according to the Cleveland Clinic ...

The drug Singulair is typically prescribed to patients with allergies or asthma. The medication has received attention recently due to its being linked to mental health side effects including ...

6mos w/perennial allergic rhinitis or <2yrs w/seasonal allergic rhinitis: not established. 6–23mos: one 4mg granule packet. 2–5yrs: one 4mg chew tab or granule packet. 6–14yrs: one 5mg chew tab.

6mos w/perennial allergic rhinitis or <2yrs w/seasonal allergic rhinitis: not established. 6–23mos: one 4mg granule packet. 2–5yrs: one 4mg chew tab or granule packet. 6–14yrs: one 5mg chew tab.

Montelukast (Singulair) held no elevated risk of depression, anxiety, suicidality, or behavioral problems for children, ...

Arthritis Foundation-funded study looks at stopping osteoarthritis inflammation with an allergy medicine ... placebo-controlled trial to test the drug montelukast (Singulair) in patients at risk for ...

Australia’s Therapeutic Goods Administration (TGA) has called for more prominent safety warnings about the neuropsychiatric ...